Open Access
Original Research Article

Table II

Treatment modality according to age, sex and selected clinical features of the lesion.

  Treatment modality P-value

Surgery Intralesional bleomycin IL Bleo. and surgery
Age group        
<20 years 7 (87.5%) 31 (75.6%) 5 (55.6%) 0.299
≥20 years 1 (12.5%) 10 (24.4%) 4 (44.4%)
Sex        
Male 3 (37.5%) 18 (43.9%) 3 (33.3%) 0.820
Female 5 (62.5%) 23 (56.1%) 6 (66.7%)
Congenital        
Yes 12 (29.3%) 3 (33.3%) 0.192
No 8 (100%) 29 (70.7%) 6 (66.7%)
Site        
Intra oral 7 (17.1%)  
Extra oral 5 (62.5%) 15 (36.6%) 1 (11.1%) 0.063
Both 3 (37.5%) 19 (46.3%) 8 (88.9%)
Total area of the lesion        
≤5cm2 4 (50%) 20 (48.8%) 2 (22.2%) 0.332
>5cm2 4 (50%) 21 (51.2%) 7 (77.8%)
Mean Percentage reduction in area of the lesion 100% 70% 84%  

NB: The last row of the third column presents % reduction in size of the lesions after bleomycin injection and before surgery was carried out.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.